Medicare to Cowl Breakthrough Gene Remedy for Leukemia, Lymphoma


THURSDAY, Aug. 8, 2019 (HealthDay Information) — A breakthrough gene remedy might be lined for sure forms of lymphoma and leukemia, Medicare says.

The remedy, known as CAR-T, boosts a affected person’s personal immune cells to battle cancer and may value lots of of 1000’s of {dollars}, the Related Press reported.

Research have proven that CAR-T is efficient in opposition to sure forms of cancers, however may cause extreme unintended effects. Using the gene remedy to deal with sure forms of leukemia and lymphoma is accredited by the U.S. Meals and Drug Administration.

Medicare thought-about the matter for months earlier than it introduced its resolution on Wednesday. The company’s insurance policies on protection can affect personal insurance coverage, the AP reported.

Copyright © 2019 HealthDay. All rights reserved.


Protect Your Health in a Rough Economy: Pictures
See Slideshow

Source link


Please enter your comment!
Please enter your name here